$1,000 invested Gilead Sciences Inc. (2021)
NASDAQ · GILD · reinvest dividends · adjusted close
●Result2021-01-04 — 2026-09-11
Today you would have
$2,913
+$1,913 (+191.34%)
GILDSPY (benchmark)
- Entry price
- $49.33
- Current price
- $143.72
- Shares
- 20.2715
- CAGR
- +20.70%
- Max Drawdown
- -26.59%
- vs SPY
- +68.72 pp
✦The story
Investing $1,000 in Gilead Sciences at the start of 2021 would have grown to $2,913 by mid-2026, a total return of +191.3%. The company entered the period known for its antiviral drugs, including treatments used during the COVID-19 pandemic, and later saw its shares re-rate higher. That beat the S&P 500's +122.6% over the same years.
#Related scenariosfor comparison
Other years for GILD